- Antenatal Treatment of Ambroxol Hydrochloride and Dexamethasone for the Prevention of Respiratory Distress Syndrome
-
Park EA, Lee KE
- KMID: 2352861
- Ewha Med J.
- 2003 Jun;26(2):105-110.
- doi: 10.12771/emj.2003.26.2.105
No abstract available in English. -
- CITED
-
- Close
- SHARE
-
- Close
- The Comparison Study of teh Effect of Ambroxol on Prevention of Infantile Respiratory Distress Syndrome in Preterm Delivery
-
Han KH, Park JD, Han CD, Huh CG, Hwong SG
- KMID: 2071928
- Korean J Perinatol.
- 1997 Mar;8(1):21-26.
This study was conducted to evaluate the effect of ambroxol on preventing the infantile respiratory distress syndrome (IRDS) in preterm birth at the Dept. of Obstetrics and Gynecology of Taegu... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of Preventive Effect of RDS and Neonatal Morbidity between Antenatal Dexamethasone versus Ambroxol Administration
-
Kim EJ, Jeon SS, Seo SS
- KMID: 1946269
- J Korean Pediatr Soc.
- 2000 Jan;43(1):13-22.
PURPOSE: Antenatal dexamethasone administration is associated with a significant lowering respiratory distress syndrome (RDS) incidence, but can increase neonatal infection. Ambroxol has been accepted as an alternative treatment to dexamethasone... -
- CITED
-
- Close
- SHARE
-
- Close
- The Preventive Effect of Antenatal Administration of Ambroxol on the Neonatal Respiratory Distress Syndrome
-
Lee ES, Kim KA, Shin SM, Koh MW, Lee TH
- KMID: 1969401
- Yeungnam Univ J Med.
- 1999 Jun;16(1):52-59.
- doi: 10.12701/yujm.1999.16.1.52
This study was conducted to evaluate the effect of antenatal ambroxol administration to the mothers who were imminent preterm delivery on preventing the neonatal respiratory distress syndrome. Forty-two preterm newborn... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Observation on the Expectorant Activity of Ambroxol
-
Shin GJ, Kyung NH, Min TH
- KMID: 1965671
- Ewha Med J.
- 1985 Dec;8(4):169-173.
- doi: 10.12771/emj.1985.8.4.169
The expectorant effect of Ambroxol was observed in 13 cases of respiratory diseases (5 cases with bronchial asthma, 2 cases with acute bronchitis, 2 cases with lung ca, 2 cases... -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of Ambroxol, S-carboxymethylcysteine, Dextromethorphan and Noscapine on Mucin Release from Airway Goblet Cells
-
Heo HJ, Lee HJ, Yoon CS, Lim SP, Seok JH, Seo UK, Lee CJ
- KMID: 2071614
- Korean J Physiol Pharmacol.
- 2005 Dec;9(6):323-326.
In the present study, we investigated whether ambroxol, S-carboxymethyl-L-cysteine, dextromethorphan and noscapine affect mucin release from airway goblet cells. Confluent primary hamster tracheal surface epithelial cells were metabolically radiolabeled and... -
- CITED
-
- Close
- SHARE
-
- Close
- Immunomodulatory Effects of Ambroxol on Airway Hyperresponsiveness and Inflammation
-
Takeda K, Miyahara N, Matsubara , Taube C, Kitamura K, Hirano A, Tanimoto M, Gelfand EW
- KMID: 2299790
- Immune Netw.
- 2016 Jun;16(3):165-175.
- doi: 10.4110/in.2016.16.3.165
Ambroxol is used in COPD and asthma to increase mucociliary clearance and regulate surfactant levels, perhaps through anti-oxidant and anti-inflammatory activities. To determine the role and effect of ambroxol in... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Efficacy of Erdosteine in Patients with Acute or Chronic Bronchitis: A Randomized, Double Blind, Comparative Study vs. Ambroxol
-
Kim SC, Lee SH, Song SH, Kim YK, Moon HS, Song JS, Park SH
- KMID: 2318111
- Tuberc Respir Dis.
- 1997 Dec;44(6):1296-1307.
BACKGROUND: Erdosteine is a thiol derivative developed for the treatement of chronic obstructive bronchitis, including acute infective exacerbation of chronic bronchitis. Erdosteine has mucomodulating and antioxidant properties and especially exhibits... -
- CITED
-
- Close
- SHARE
-
- Close
